Journal
CIRCULATION
Volume 134, Issue 2, Pages 126-129Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.116.022965
Keywords
Editorials; everolimus; lamin type A; lonafarnib; morpholinos; progeria; rare diseases; translational medical research